Wellesley Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$931K Sell
3,665
-550
-13% -$136K 0.32% 28
2020
Q2
$994K Sell
4,215
-908
-18% -$207K 0.35% 27
2020
Q1
$1.04M Sell
5,123
-898
-15% -$196K 0.41% 24
2019
Q4
$1.45M Buy
6,021
+596
+11% +$131K 0.45% 22
2019
Q3
$1.05M Buy
5,425
+288
+6% +$55.3K 0.34% 33
2019
Q2
$946K Sell
5,137
-785
-13% -$141K 0.33% 36
2019
Q1
$1.13M Sell
5,922
-90
-1% -$17.2K 0.39% 36
2018
Q4
$1.17M Sell
6,012
-147
-2% -$28.7K 0.42% 35
2018
Q3
$1.28M Buy
6,159
+336
+6% +$66.2K 0.42% 39
2018
Q2
$1.07M Buy
5,823
+2
+0% +$354 0.37% 48
2018
Q1
$992K Buy
5,821
+370
+7% +$67.9K 0.36% 53
2017
Q4
$947K Buy
5,451
+313
+6% +$55.4K 0.36% 51
2017
Q3
$957K Sell
5,138
-272
-5% -$48.2K 0.39% 46
2017
Q2
$931K Buy
5,410
+627
+13% +$102K 0.39% 49
2017
Q1
$784K Buy
4,783
+770
+19% +$128K 0.35% 54
2016
Q4
$586K Buy
4,013
+1,128
+39% +$170K 0.28% 62
2016
Q3
$481K Buy
+2,885
New +$488K 0.25% 66

Other funds holding AMGN

Wellesley Investment Partners's AMGN Position: Q3 2020 in Review

Wellesley Investment Partners reduced its Amgen (AMGN) stake by 13% in Q3 2020, selling an estimated $136K and leaving 3,665 shares worth $931K. The position accounts for 0.32% of the portfolio, ranked #28.

Wellesley Investment Partners first reported a position in AMGN in Q3 2016 and has held it in 17 quarters since. The position peaked at $1.45M in Q4 2019. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Wellesley Investment Partners held 3,665 shares of Amgen worth $931K as of Q3 2020.
  • Wellesley Investment Partners sold 550 Amgen shares in Q3 2020, an estimated $136K.
  • Amgen made up 0.32% of Wellesley Investment Partners's portfolio in Q3 2020, its #28 holding.
  • Wellesley Investment Partners first reported a position in Amgen in Q3 2016 and has held it in 17 quarters since.
  • Wellesley Investment Partners's Amgen position peaked at $1.45M in Q4 2019.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Wellesley Investment Partners's 13F filing for Q3 2020, filed 30 Oct 2020.